SEC Tracker
Get the app
Person · CIK 1969082

Jeff Cislini

SVP & General Counsel at Revolution Medicines

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$17.4M
Noticed on Form 144$21.2M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Revolution Medicines RVMDCommon StockDirectly51,776Sep 25, 2026 · Filing · EDGAR
Revolution Medicines RVMDStock Option (Right to Buy)
exercise $21.61, expires Aug 31, 2032, into Common Stock
Directly3,500Aug 21, 2026 · Filing · EDGAR

Sold and noticed by quarter

Jeff Cislini: dollars sold on Form 4 and noticed on Form 144 per quarter, Q2 2023 to Q4 2026$16.7M$0Q2 2023: $0 noticed on Form 144Q2 2023: $31K sold on Form 4Q3 2023: $134K noticed on Form 144Q3 2023: $133K sold on Form 4Q4 2023: $61K noticed on Form 144Q4 2023: $64K sold on Form 4Q1 2024: $132K noticed on Form 144Q1 2024: $127K sold on Form 4Q2 2024: $206K noticed on Form 144Q2 2024: $201K sold on Form 4Q3 2024: $155K noticed on Form 144Q3 2024: $162K sold on Form 4Q4 2024: $848K noticed on Form 144Q4 2024: $874K sold on Form 4Q1 2025: $240K noticed on Form 144Q1 2025: $233K sold on Form 4Q2 2025: $151K noticed on Form 144Q2 2025: $151K sold on Form 4Q3 2025: $165K noticed on Form 144Q3 2025: $165K sold on Form 4Q4 2025: $1.7M noticed on Form 144Q4 2025: $1.8M sold on Form 4Q1 2026: $424K noticed on Form 144Q1 2026: $397K sold on Form 4Q2 2026: $255K noticed on Form 144Q2 2026: $337K sold on Form 4Q3 2026: $16.7M noticed on Form 144Q3 2026: $12.7M sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q2 2023Q1 2024Q4 2024Q3 2025Q2 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q3 2026$12.7M$16.7M
Q2 2026$337K$255K
Q1 2026$397K$424K
Q4 2025$1.8M$1.7M
Q3 2025$165K$165K
Q2 2025$151K$151K
Q1 2025$233K$240K
Q4 2024$874K$848K
Q3 2024$162K$155K
Q2 2024$201K$206K
Q1 2024$127K$132K
Q4 2023$64K$61K
Q3 2023$133K$134K
Q2 2023$31K—

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
Revolution Medicines RVMD · Etrade Financial · 10b5-1 plan adopted May 31, 2023 · 10 notices
Sep 15, 20263,272 · ~$667KSep 15, 2026Not sold yetFiling · EDGAR
Jun 15, 20261,656 · ~$255KJun 15, 2026Not sold within 90 daysFiling · EDGAR
Mar 13, 20262,053 · ~$204KMar 16, 2026Partly sold Sold 1,795 at $99.48 on Mar 17 · $179K likely match Form 4Filing · EDGAR
Dec 12, 20252,614 · ~$203KDec 15, 2025Partly sold Sold 908 at $115.60 on Jan 21 · $105K likely match Form 4Filing · EDGAR
Sep 15, 20251,842 · ~$86KSep 15, 2025Partly sold Sold 1,799 at $44.26 on Sep 24 · $80K likely match Form 4Filing · EDGAR
Jun 13, 20251,842 · ~$75KJun 16, 2025Not sold within 90 daysFiling · EDGAR
Mar 14, 20251,650 · ~$64KMar 17, 2025Partly sold Sold 1,458 at $39.04 on Mar 17 · $57K likely match Form 4Filing · EDGAR
Dec 16, 20241,432 · ~$64KDec 16, 2024Not sold within 90 daysFiling · EDGAR
Sep 16, 20241,433 · ~$60KSep 16, 2024Not sold within 90 daysFiling · EDGAR
Jun 14, 20241,700 · ~$69KJun 17, 2024Not sold within 90 daysFiling · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted May 22, 2026 · 1 notice
Aug 21, 202675,894 · ~$16.1MAug 21, 2026Partly sold Sold 61,025 in 9 sales, Aug 21 to Sep 25 · $12.7M likely match Form 4 (1) · Form 4 (2) · Form 4 (3)Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 13, 2025 · 6 notices
Mar 19, 20261,163 · ~$114KMar 19, 2026Sold as noticed Sold 1,163 at $97.44 on Mar 19 · $113K Form 4Filing · EDGAR
Jan 21, 2026908 · ~$106KJan 21, 2026Not sold within 90 daysFiling · EDGAR
Nov 18, 202513,388 · ~$926KNov 18, 2025Sold as noticed Sold 13,388 at $70.14 on Nov 18 · $939K Form 4Filing · EDGAR
Oct 17, 202512,000 · ~$596KOct 17, 2025Sold as noticed Sold 12,000 at $55.00 on Oct 17 · $660K Form 4Filing · EDGAR
Sep 24, 20251,799 · ~$80KSep 24, 2025Not sold within 90 daysFiling · EDGAR
Jun 20, 20251,912 · ~$76KJun 20, 2025Partly sold Sold 1,878 at $39.83 on Jun 16 · $75K likely match Form 4Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 20, 2024 · 7 notices
Mar 20, 20252,041 · ~$79KMar 20, 2025Sold as noticed Sold 2,041 at $38.71 on Mar 20 · $79K Form 4Filing · EDGAR
Jan 21, 20252,406 · ~$97KJan 21, 2025Sold as noticed Sold 2,406 at $40.50 on Jan 21 · $97K Form 4Filing · EDGAR
Nov 15, 20242,554 · ~$147KNov 15, 2024Sold as noticed Sold 2,554 at $55.13 on Nov 15 · $141K Form 4Filing · EDGAR
Nov 6, 20246,000 · ~$341KNov 6, 2024Sold as noticed Sold 6,000 at $60.00 on Nov 6 · $360K Form 4Filing · EDGAR
Oct 11, 20246,000 · ~$297KOct 11, 2024Sold as noticed Sold 6,000 at $50.17 on Oct 11 · $301K Form 4Filing · EDGAR
Jul 9, 20242,399 · ~$95KJul 9, 2024Sold as noticed Sold 2,399 at $40.83 on Jul 9 · $98K Form 4Filing · EDGAR
Jun 26, 20242,000 · ~$78KJun 26, 2024Sold as noticed Sold 2,000 at $38.47 on Jun 26 · $77K Form 4Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 27, 2023 · 5 notices
May 21, 20241,500 · ~$60KMay 21, 2024Sold as noticed Sold 1,500 in 2 sales, May 21 to May 21 · $59K Form 4Filing · EDGAR
Mar 27, 20241,500 · ~$45KMar 27, 2024Sold as noticed Sold 1,500 in 2 sales, Mar 27 to Mar 27 · $46K Form 4Filing · EDGAR
Jan 22, 20241,500 · ~$40KJan 22, 2024Sold as noticed Sold 1,500 at $27.00 on Jan 22 · $41K Form 4Filing · EDGAR
Nov 20, 20231,500 · ~$32KNov 20, 2023Sold as noticed Sold 1,500 at $21.70 on Nov 20 · $33K Form 4Filing · EDGAR
Sep 28, 20232,000 · ~$58KSep 28, 2023Sold as noticed Sold 2,000 in 2 sales, Sep 28 to Sep 28 · $56K Form 4Filing · EDGAR
Revolution Medicines RVMD · Morgan Stanley Wealth Management · 10b5-1 plan adopted May 31, 2023 · 2 notices
Mar 15, 20241,414 · ~$47KMar 15, 2024Partly sold Sold 1,252 at $31.58 on Mar 18 · $40K likely match Form 4Filing · EDGAR
Dec 14, 20231,193 · ~$29KDec 18, 2023Not sold within 90 daysFiling · EDGAR
Revolution Medicines RVMD · Morgan Stanley Wealth Management · 10b5-1 plan adopted Mar 27, 2023 · 2 notices
Sep 19, 20231,214 · ~$38KSep 18, 2023Sold as noticed Sold 1,214 at $31.31 on Sep 18 · $38K Form 4Filing · EDGAR
Jul 31, 20231,500 · ~$39KJul 31, 2023Sold as noticed Sold 1,500 at $26.02 on Jul 31 · $39K Form 4Filing · EDGAR
Sales without a matching Form 144 · 9 sales
No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
———Sold without notice Revolution Medicines (RVMD): Sold 2,157 at $156.12 on Jun 16, 2026 · $337K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 2,688 at $76.82 on Dec 16, 2025 · $206K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,869 at $45.82 on Sep 16, 2025 · $86K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,912 at $39.61 on Jun 20, 2025 · $76K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,599 at $45.40 on Dec 16, 2024 · $73K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,454 at $44.19 on Sep 16, 2024 · $64K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,757 at $37.39 on Jun 17, 2024 · $66K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,229 at $25.90 on Dec 18, 2023 · $32K (10b5-1 plan)Filing · EDGAR
———Sold without notice Revolution Medicines (RVMD): Sold 1,239 at $25.14 on Jun 20, 2023 · $31KFiling · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Revolution Medicines RVMD SVP & General Counsel · filings 2023 to 2026 · sold $17.4M · $21.2M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Sep 25, 2026Sale under a 10b5-1 plan−765$207.32$159K51,776 directFiling · EDGAR
Sep 16, 2026Sale under a 10b5-1 plan−52$195.01$10K55,855 directFiling · EDGAR
Sep 16, 2026Sale under a 10b5-1 plan−3,314$199.30$660K52,541 directFiling · EDGAR
Aug 21, 2026Option or RSU exercised or converted+29,680$18.56$551K86,201 directFiling · EDGAR
Aug 21, 2026Option or RSU exercised or converted+26,600$21.61$575K112,801 directFiling · EDGAR
Aug 21, 2026Sale under a 10b5-1 plan−3,400$207.24$705K109,401 directFiling · EDGAR
Aug 21, 2026Sale under a 10b5-1 plan−17,323$208.37$3.6M92,078 directFiling · EDGAR
Aug 21, 2026Sale under a 10b5-1 plan−25,817$209.25$5.4M66,261 directFiling · EDGAR
Aug 21, 2026Sale under a 10b5-1 plan−2,540$210.26$534K63,721 directFiling · EDGAR
Aug 21, 2026Sale under a 10b5-1 plan−4,500$211.34$951K59,221 directFiling · EDGAR
Aug 21, 2026Sale under a 10b5-1 plan−3,314$212.06$703K55,907 directFiling · EDGAR
Aug 21, 2026Option or RSU exercised or converted
Stock Option (Right to Buy)
−29,6800 directFiling · EDGAR
Aug 21, 2026Option or RSU exercised or converted
Stock Option (Right to Buy)
−26,6003,500 directFiling · EDGAR
Jun 16, 2026Sale under a 10b5-1 plan−2,157$156.12$337K56,521 directFiling · EDGAR
Mar 19, 2026Sale under a 10b5-1 plan−1,163$97.44$113K58,518 directFiling · EDGAR
Mar 17, 2026Sale under a 10b5-1 plan−1,795$99.48$179K59,681 directFiling · EDGAR
Mar 1, 2026Grant or award from the company+14,50061,476 directFiling · EDGAR
Mar 1, 2026Grant or award from the company
Stock Option (Right to Buy)
+32,50032,500 directFiling · EDGAR
Jan 21, 2026Sale under a 10b5-1 plan−908$115.60$105K46,976 directFiling · EDGAR
Dec 16, 2025Sale under a 10b5-1 plan−2,688$76.82$206K47,884 directFiling · EDGAR
Nov 18, 2025Option or RSU exercised or converted+13,388$42.45$568K63,813 directFiling · EDGAR
Nov 18, 2025Sale under a 10b5-1 plan−13,388$70.14$939K50,425 directFiling · EDGAR
Nov 18, 2025Option or RSU exercised or converted
Stock Option (Right to Buy)
−13,3880 directFiling · EDGAR
Oct 17, 2025Option or RSU exercised or converted+12,000$36.57$439K62,425 directFiling · EDGAR
Oct 17, 2025Sale under a 10b5-1 plan−12,000$55.00$660K50,425 directFiling · EDGAR
Oct 17, 2025Option or RSU exercised or converted
Stock Option (Right to Buy)
−12,00018,000 directFiling · EDGAR
Sep 24, 2025Sale under a 10b5-1 plan−1,799$44.26$80K50,425 directFiling · EDGAR
Sep 16, 2025Sale under a 10b5-1 plan−1,869$45.82$86K52,224 directFiling · EDGAR
Jun 20, 2025Sale under a 10b5-1 plan−1,912$39.61$76K54,093 directFiling · EDGAR
Jun 16, 2025Sale under a 10b5-1 plan−1,878$39.83$75K56,005 directFiling · EDGAR
Mar 20, 2025Sale under a 10b5-1 plan−2,041$38.71$79K57,723 directFiling · EDGAR
Mar 17, 2025Sale under a 10b5-1 plan−1,458$39.04$57K59,764 directFiling · EDGAR
Mar 1, 2025Grant or award from the company+22,00061,222 directFiling · EDGAR
Mar 1, 2025Grant or award from the company
Stock Option (Right to Buy)
+77,00077,000 directFiling · EDGAR
Jan 21, 2025Sale under a 10b5-1 plan−2,406$40.50$97K39,222 directFiling · EDGAR
Dec 16, 2024Sale under a 10b5-1 plan−1,599$45.40$73K41,628 directFiling · EDGAR
Nov 15, 2024Sale under a 10b5-1 plan−2,554$55.13$141K43,080 directFiling · EDGAR
Nov 6, 2024Option or RSU exercised or converted+6,000$36.57$219K51,634 directFiling · EDGAR
Nov 6, 2024Sale under a 10b5-1 plan−6,000$60.00$360K45,634 directFiling · EDGAR
Nov 6, 2024Option or RSU exercised or converted
Stock Option (Right to Buy)
−6,00030,000 directFiling · EDGAR
Oct 11, 2024Option or RSU exercised or converted+6,000$36.57$219K51,634 directFiling · EDGAR
Oct 11, 2024Sale under a 10b5-1 plan−6,000$50.17$301K45,634 directFiling · EDGAR
Oct 11, 2024Option or RSU exercised or converted
Stock Option (Right to Buy)
−6,00036,000 directFiling · EDGAR
Sep 16, 2024Sale under a 10b5-1 plan−1,454$44.19$64K45,634 directFiling · EDGAR
Jul 9, 2024Sale under a 10b5-1 plan−2,399$40.83$98K47,088 directFiling · EDGAR
Jun 26, 2024Sale under a 10b5-1 plan−2,000$38.47$77K49,487 directFiling · EDGAR
Jun 17, 2024Sale under a 10b5-1 plan−1,757$37.39$66K51,487 directFiling · EDGAR
May 21, 2024Sale under a 10b5-1 plan−700$38.67$27K53,674 directFiling · EDGAR
May 21, 2024Sale under a 10b5-1 plan−800$39.51$32K52,874 directFiling · EDGAR
Mar 27, 2024Sale under a 10b5-1 plan−700$30.38$21K55,174 directFiling · EDGAR
Mar 27, 2024Sale under a 10b5-1 plan−800$31.52$25K54,374 directFiling · EDGAR
Mar 18, 2024Sale under a 10b5-1 plan−1,252$31.58$40K55,874 directFiling · EDGAR
Mar 1, 2024Grant or award from the company+21,00057,126 directFiling · EDGAR
Mar 1, 2024Grant or award from the company
Stock Option (Right to Buy)
+73,50073,500 directFiling · EDGAR
Jan 22, 2024Sale under a 10b5-1 plan−1,500$27.00$41K36,126 directFiling · EDGAR
Dec 18, 2023Sale under a 10b5-1 plan−1,229$25.90$32K37,284 directFiling · EDGAR
Nov 20, 2023Sale under a 10b5-1 plan−1,500$21.70$33K38,513 directFiling · EDGAR
Sep 28, 2023Sale under a 10b5-1 plan−1,798$28.10$51K40,215 directFiling · EDGAR
Sep 28, 2023Sale under a 10b5-1 plan−202$29.06$6K40,013 directFiling · EDGAR
Sep 18, 2023Open-market or private sale−1,214$31.31$38K42,013 directFiling · EDGAR

2 earlier transactions are in the filing list below.

All 71 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Sep 29, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 18, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 15, 2026Form 144Revolution Medicines RVMDFiling · EDGAR
Aug 25, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Aug 21, 2026Form 144Revolution Medicines RVMDFiling · EDGAR
Jun 18, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Jun 15, 2026Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 19, 2026Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 19, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Mar 13, 2026Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 3, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Jan 23, 2026Form 4Revolution Medicines RVMDFiling · EDGAR
Jan 21, 2026Form 144Revolution Medicines RVMDFiling · EDGAR
Dec 18, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Dec 12, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Nov 20, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Nov 18, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Oct 20, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Oct 17, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Sep 26, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 24, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Sep 18, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 15, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Jun 23, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Jun 20, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Jun 18, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Jun 13, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 24, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Mar 20, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 19, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Mar 14, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 4, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Jan 22, 2025Form 4Revolution Medicines RVMDFiling · EDGAR
Jan 21, 2025Form 144Revolution Medicines RVMDFiling · EDGAR
Dec 18, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Dec 16, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Nov 19, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Nov 15, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Nov 8, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Nov 6, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Oct 15, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Oct 11, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Sep 18, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 16, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Jul 10, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Jul 9, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Jun 27, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Jun 26, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Jun 20, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Jun 14, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
May 22, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
May 21, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 28, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Mar 27, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 20, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Mar 15, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Mar 5, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Jan 24, 2024Form 4Revolution Medicines RVMDFiling · EDGAR
Jan 22, 2024Form 144Revolution Medicines RVMDFiling · EDGAR
Dec 20, 2023Form 4Revolution Medicines RVMDFiling · EDGAR
Dec 14, 2023Form 144Revolution Medicines RVMDFiling · EDGAR
Nov 20, 2023Form 144Revolution Medicines RVMDFiling · EDGAR
Nov 20, 2023Form 4Revolution Medicines RVMDFiling · EDGAR
Oct 2, 2023Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 28, 2023Form 144Revolution Medicines RVMDFiling · EDGAR
Sep 20, 2023Form 4Revolution Medicines RVMDFiling · EDGAR
Sep 19, 2023Form 144Revolution Medicines RVMDFiling · EDGAR
Aug 1, 2023Form 4Revolution Medicines RVMDFiling · EDGAR
Jul 31, 2023Form 144Revolution Medicines RVMDFiling · EDGAR
Jun 22, 2023Form 4Revolution Medicines RVMDFiling · EDGAR
Mar 29, 2023Form 3Revolution Medicines RVMDFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.